ArticleEnvironmental health : a global access science source2026
Mitochondrial dysfunction as a potential pathway linking DL-PCB exposure to intrauterine growth retardation.
Article in Environmental health : a global access science source, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgraoundDioxin-like polychlorinated biphenyls (DL-PCBs) are persistent organic pollutants with known endocrine-disrupting and developmental toxicity. Increasing evidence suggests that prenatal exposure to DL-PCBs may adversely affect fetal growth; however, few studies have examined congener-specific and mixture-level effects, and the underlying biological mechanisms remain unclear. This study aimed to assess the relationship between umbilical cord DL-PCB concentrations and key fetal growth indicators including birth weight (BW), birth length (BL), and head circumference (HC), and to explore whether mitochondrial dysfunction mediates these effects.
methodsA total of 5421 mother-infant pairs were recruited between 2022 and 2024 from a multicenter birth cohort in China. Twelve WHO-designated DL-PCB congeners were quantified in umbilical cord blood using gas chromatography-mass spectrometry (GC-MS). We employed multivariable linear regression, sex-stratified models, Bayesian kernel machine regression, generalized weighted quantile sum (gWQS), quantile g-computation (g-comp), and mediation analysis to evaluate individual and mixture effects.
resultsEight DL-PCBs, particularly PCB-77 and PCB-126, were significantly associated with reduced BW (ranging from - 26.52 g to - 80.05 g per IQR increase). PCB-77 and PCB-126 were also negatively associated with HC, while no DL-PCBs showed significant associations with BL. Although inverse associations appeared stronger in boys, sex interactions were not statistically significant. Mediation analysis revealed that mitochondrial DNA content partially mediated the relationship between several DL-PCBs (e.g., PCB-77, PCB-81, PCB-118, PCB-126) and BW, with up to 10.76% of the total effect explained. Mixture models confirmed negative associations with BW and HC, with g-comp estimating a 161.95 g BW reduction per cumulative exposure unit. Bayesian kernel machine regression further identified PCB-77 and PCB-126 as dominant contributors.
conclusionThese findings suggest that mitochondrial dysfunction may be a mechanistic pathway linking prenatal DL-PCB exposure to intrauterine growth restriction, especially reduced birth weight, highlighting potential developmental risks from environmental contamination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.